chr12-14669740-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004963.4(GUCY2C):āc.1264A>Gā(p.Asn422Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000319 in 1,569,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GUCY2C | NM_004963.4 | c.1264A>G | p.Asn422Asp | missense_variant | 10/27 | ENST00000261170.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GUCY2C | ENST00000261170.5 | c.1264A>G | p.Asn422Asp | missense_variant | 10/27 | 1 | NM_004963.4 | P1 | |
GUCY2C-AS1 | ENST00000501178.2 | n.199-2526T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000814 AC: 2AN: 245816Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 132950
GnomAD4 exome AF: 0.00000282 AC: 4AN: 1416832Hom.: 0 Cov.: 24 AF XY: 0.00000141 AC XY: 1AN XY: 707514
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.1264A>G (p.N422D) alteration is located in exon 10 (coding exon 10) of the GUCY2C gene. This alteration results from a A to G substitution at nucleotide position 1264, causing the asparagine (N) at amino acid position 422 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at